Brief

On June 5, the National Health Surveillance Agency (Anvisa) issued an update regarding Anvisa recommends caution when reading rapid tests for diagnosing malaria. The agency published a safety report on the risk of false-negative results in rapid tests for malaria diagnosis, particularly in patients with confirmed infections. This is due to weak line detection in individuals with subsequently confirmed infection.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies